Completed | December 2017

Demographic, Clinical and Laboratory Characteristics of Patients Receiving Darunavir/Etravirine – Data Abstraction in Lesotho, Kenya, Zambia, Swaziland

Overview

Country:

Lesotho; Kenya; Zambia; Eswatini

Subject Matter:

Innovative Technologies; Pediatric and Adolescent Testing, Care, and Treatment

This retrospective baseline study, funded by Johnson and Johnson, collected demographic, clinical, and laboratory indicators on children and adolescents initiated on Darunavir/Etravirine (DRV/ETR) through the New Horizons Collaborative in participating countries to inform future data collection efforts.

Data Collection Period: November 2015-June 2016

Findings published in the Pediatric Infectious Disease Journal, July 2018: “Characteristics of Treatment-experienced HIV-infected African Children and Adolescents Initiating Darunavir and/or Etravirine-based Antiretroviral Treatment“

Explore Other Research

In Analysis Assessing the Effectiveness of Integration of Rapid Antigen Testing for SARS-CoV-2 in MNCH, HIV and TB Services in Cameroon and Kenya: A Pre- and Post- Implementation Evaluation (Effectiveness Integration) Adult Testing, Care, and Treatment; COVID-19; Pediatric and Adolescent Testing, Care, and Treatment
In Analysis Evaluation of the Differentiated Care Model for Advanced HIV Disease in Côte d’Ivoire DICACI study Adult Testing, Care, and Treatment; Pediatric and Adolescent Testing, Care, and Treatment
In Analysis Evaluation of a National Program for Management of Advanced HIV Disease in Lesotho Adult Testing, Care, and Treatment; Pediatric and Adolescent Testing, Care, and Treatment
All Research